FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210471886> ?p ?o ?g. }

• W4210471886 endingPage "109263" @default.
• W4210471886 startingPage "109263" @default.
• W4210471886 abstract "COVID-19 has likely affected the delivery of interventions to prevent blood-borne viruses (BBVs) among people who inject drugs (PWID). We examined the impact of the first wave of COVID-19 in Scotland on: 1) needle and syringe provision (NSP), 2) opioid agonist therapy (OAT) and 3) BBV testing. An interrupted time series study design; 23rd March 2020 (date of the first ‘lockdown’) was chosen as the key date. The number of HIV tests and HCV tests in drug services/prisons, and the number of needles/syringes (N/S) distributed decreased by 94% (RR=0.062, 95% CI 0.041–0.094, p < 0.001), 95% (RR=0.049, 95% CI 0.034–0.069, p < 0.001) and 18% (RR = 0.816, 95% CI 0.750–0.887, p < 0.001), respectively, immediately after lockdown. Post-lockdown, an increasing trend was observed relating to the number of N/S distributed (0.6%; RR = 1.006, 95% CI 1.001–1.012, p = 0.015), HIV tests (12.1%; RR = 1.121, 95% CI 1.092–1.152, p < 0.001) and HCV tests (13.2%; RR = 1.132, 95 CI 1.106–1.158, p < 0.001). Trends relating to the total amount of methadone prescribed remained stable, but a decreasing trend in the number of prescriptions (2.4%; RR = 0.976, 95% CI 0.959–0.993, p = 0.006) and an increasing trend in the quantity prescribed per prescription (2.8%; RR = 1.028, 95% CI 1.013–1.042, p < 0.001) was observed post-lockdown. COVID-19 impacted the delivery of BBV prevention services for PWID in Scotland. While there is evidence of service recovery; further effort is likely required to return some intervention coverage to pre-pandemic levels in the context of subsequent waves of COVID-19." @default.
• W4210471886 created "2022-02-08" @default.
• W4210471886 creator A5001076131 @default.
• W4210471886 creator A5001213895 @default.
• W4210471886 creator A5003364789 @default.
• W4210471886 creator A5004545282 @default.
• W4210471886 creator A5006458734 @default.
• W4210471886 creator A5007119843 @default.
• W4210471886 creator A5008881499 @default.
• W4210471886 creator A5014497784 @default.
• W4210471886 creator A5016888539 @default.
• W4210471886 creator A5026448955 @default.
• W4210471886 creator A5028684820 @default.
• W4210471886 creator A5041209639 @default.
• W4210471886 creator A5042374950 @default.
• W4210471886 creator A5062271696 @default.
• W4210471886 creator A5065624143 @default.
• W4210471886 creator A5071196544 @default.
• W4210471886 creator A5076842466 @default.
• W4210471886 creator A5089367007 @default.
• W4210471886 date "2022-03-01" @default.
• W4210471886 modified "2023-10-16" @default.
• W4210471886 title "Examining the impact of the first wave of COVID-19 and associated control measures on interventions to prevent blood-borne viruses among people who inject drugs in Scotland: an interrupted time series study" @default.
• W4210471886 cites W1991781441 @default.
• W4210471886 cites W2110132657 @default.
• W4210471886 cites W2307959844 @default.
• W4210471886 cites W2416547532 @default.
• W4210471886 cites W2606014799 @default.
• W4210471886 cites W2765091655 @default.
• W4210471886 cites W2939292838 @default.
• W4210471886 cites W3002144723 @default.
• W4210471886 cites W3014641702 @default.
• W4210471886 cites W3019877285 @default.
• W4210471886 cites W3020359399 @default.
• W4210471886 cites W3022725611 @default.
• W4210471886 cites W3025082979 @default.
• W4210471886 cites W3035173223 @default.
• W4210471886 cites W3040596415 @default.
• W4210471886 cites W3041488668 @default.
• W4210471886 cites W3042190013 @default.
• W4210471886 cites W3043924968 @default.
• W4210471886 cites W3045562053 @default.
• W4210471886 cites W3047701236 @default.
• W4210471886 cites W3048332638 @default.
• W4210471886 cites W3082445848 @default.
• W4210471886 cites W3086642606 @default.
• W4210471886 cites W3106187707 @default.
• W4210471886 cites W3112597207 @default.
• W4210471886 cites W3118291217 @default.
• W4210471886 cites W3120077942 @default.
• W4210471886 cites W3121269706 @default.
• W4210471886 cites W3121489504 @default.
• W4210471886 cites W3131286856 @default.
• W4210471886 cites W3134741282 @default.
• W4210471886 cites W3135294192 @default.
• W4210471886 cites W3137914276 @default.
• W4210471886 cites W3139458024 @default.
• W4210471886 cites W3158184655 @default.
• W4210471886 cites W3159914426 @default.
• W4210471886 cites W3185353070 @default.
• W4210471886 cites W3186009275 @default.
• W4210471886 cites W3189748638 @default.
• W4210471886 cites W3192018578 @default.
• W4210471886 doi "https://doi.org/10.1016/j.drugalcdep.2021.109263" @default.
• W4210471886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35120807" @default.
• W4210471886 hasPublicationYear "2022" @default.
• W4210471886 type Work @default.
• W4210471886 citedByCount "12" @default.
• W4210471886 countsByYear W42104718862022 @default.
• W4210471886 countsByYear W42104718862023 @default.
• W4210471886 crossrefType "journal-article" @default.
• W4210471886 hasAuthorship W4210471886A5001076131 @default.
• W4210471886 hasAuthorship W4210471886A5001213895 @default.
• W4210471886 hasAuthorship W4210471886A5003364789 @default.
• W4210471886 hasAuthorship W4210471886A5004545282 @default.
• W4210471886 hasAuthorship W4210471886A5006458734 @default.
• W4210471886 hasAuthorship W4210471886A5007119843 @default.
• W4210471886 hasAuthorship W4210471886A5008881499 @default.
• W4210471886 hasAuthorship W4210471886A5014497784 @default.
• W4210471886 hasAuthorship W4210471886A5016888539 @default.
• W4210471886 hasAuthorship W4210471886A5026448955 @default.
• W4210471886 hasAuthorship W4210471886A5028684820 @default.
• W4210471886 hasAuthorship W4210471886A5041209639 @default.
• W4210471886 hasAuthorship W4210471886A5042374950 @default.
• W4210471886 hasAuthorship W4210471886A5062271696 @default.
• W4210471886 hasAuthorship W4210471886A5065624143 @default.
• W4210471886 hasAuthorship W4210471886A5071196544 @default.
• W4210471886 hasAuthorship W4210471886A5076842466 @default.
• W4210471886 hasAuthorship W4210471886A5089367007 @default.
• W4210471886 hasBestOaLocation W42104718862 @default.
• W4210471886 hasConcept C105795698 @default.
• W4210471886 hasConcept C118552586 @default.
• W4210471886 hasConcept C126322002 @default.
• W4210471886 hasConcept C144024400 @default.
• W4210471886 hasConcept C149923435 @default.
• W4210471886 hasConcept C159047783 @default.
• W4210471886 hasConcept C2426938 @default.
• W4210471886 hasConcept C27415008 @default.

• next